The funds will be used to develop personalized treatments through collaborations within the Boston community, speed up clinical trials, and remove data bottlenecks.
The Harris Center for Precision Wellness will leverage emerging technologies in genomics, digital health, and data science.
The gift is from a group of more than 20 philanthropists and will be used to develop a rapid diagnostic test for drug-resistant TB.
The gift from the Hersch Foundation also will be used to create the Julie K. Hersch Chair in depression research and clinical care.
With funding from CurePSP, the collaborators will investigate the genetic causes of the disease, which affects a patients' speech, mobility, balance, and other abilities.
Parlaying expertise in genetics, pathology, radiology, immunology, and gastroenterology, the center will focus on personalized medicine for Crohn's disease.
Under a pilot run, CytoVale, a developer of technologies for high-throughput single-cell analysis, has received funding and been assigned a mentor from BD.
Among the uses of the funding, UW will conduct exome sequencing to determine a patient's risk for developing the disease.
The gift will go toward the creation of theBartBarlogieCenterfor Molecular Diagnostics and the Celgene Distinguished Endowed Chair for Molecular Therapeutics.
The majority of the funding will be used to establish a cancer metabolomics research center on Technion's campus.
The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.
A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.
The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.
In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.